Company name
Basilea Pharmaceutica International Ltd, Allschwil
Company profile
Basilea (SIX:BSLN) is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative treatments for severe bacterial and fungal infections. We successfully launched two hospital brands, the antifungal Cresemba and the antibiotic Zevtera. In addition, we have preclinical and clinical anti-infective assets in our portfolio.
Date, time and room information
Monday, May 4, 16:45 - 17:00, room Montreal
Category
Commercial stage company
Title of the presentation
Creating anti-infective opportunities
Speaker information
| Name | Position | Institution |
|---|---|---|
| Dr. Laurenz Kellenberger | Chief Scientific Officer |
